FASTA searches a protein or DNA sequence data bank 36.3.4 Apr, 2011 Please cite: W.R. Pearson & D.J. Lipman PNAS (1988) 85:2444-2448 Query: pF1KE4481, 498 aa 1>>>pF1KE4481 498 - 498 aa - 498 aa Library: /omim/omim.rfq.tfa 60827320 residues in 85289 sequences Statistics: Expectation_n fit: rho(ln(x))= 7.2318+/-0.000411; mu= 9.0235+/- 0.026 mean_var=116.6518+/-23.453, 0's: 0 Z-trim(114.5): 22 B-trim: 338 in 1/57 Lambda= 0.118749 statistics sampled from 24429 (24451) to 24429 sequences Algorithm: FASTA (3.7 Nov 2010) [optimized] Parameters: BL50 matrix (15:-5), open/ext: -10/-2 ktup: 2, E-join: 1 (0.656), E-opt: 0.2 (0.287), width: 16 Scan time: 6.400 The best scores are: opt bits E(85289) NP_004799 (OMIM: 603801) glycylpeptide N-tetradeca ( 498) 3343 584.0 3.3e-166 XP_005252699 (OMIM: 603801) PREDICTED: glycylpepti ( 495) 3308 578.0 2.1e-164 XP_016872436 (OMIM: 603801) PREDICTED: glycylpepti ( 502) 3308 578.0 2.1e-164 NP_001295224 (OMIM: 603801) glycylpeptide N-tetrad ( 485) 2814 493.4 6.1e-139 XP_016872438 (OMIM: 603801) PREDICTED: glycylpepti ( 482) 2779 487.4 3.9e-137 XP_016872437 (OMIM: 603801) PREDICTED: glycylpepti ( 489) 2779 487.4 3.9e-137 XP_016872442 (OMIM: 603801) PREDICTED: glycylpepti ( 411) 2772 486.2 7.8e-137 XP_016872441 (OMIM: 603801) PREDICTED: glycylpepti ( 415) 2737 480.2 5e-135 NP_066565 (OMIM: 160993) glycylpeptide N-tetradeca ( 496) 2450 431.0 3.7e-120 XP_011523160 (OMIM: 160993) PREDICTED: glycylpepti ( 515) 2125 375.4 2.2e-103 XP_006717602 (OMIM: 603801) PREDICTED: glycylpepti ( 441) 1646 293.3 9.7e-79 XP_016872439 (OMIM: 603801) PREDICTED: glycylpepti ( 445) 1646 293.3 9.8e-79 XP_016872440 (OMIM: 603801) PREDICTED: glycylpepti ( 428) 1349 242.4 2e-63 >>NP_004799 (OMIM: 603801) glycylpeptide N-tetradecanoyl (498 aa) initn: 3343 init1: 3343 opt: 3343 Z-score: 3105.0 bits: 584.0 E(85289): 3.3e-166 Smith-Waterman score: 3343; 99.8% identity (100.0% similar) in 498 aa overlap (1-498:1-498) 10 20 30 40 50 60 pF1KE4 MAEDSESAASQQSLELDDQDTCGIDGDNEEETEHAKGSPGGYLGAKKKKKKQKRKKEKPN :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: NP_004 MAEDSESAASQQSLELDDQDTCGIDGDNEEETEHAKGSPGGYLGAKKKKKKQKRKKEKPN 10 20 30 40 50 60 70 80 90 100 110 120 pF1KE4 SGGTKSDSASDSQEIKIQQPSKNPSVPMQKLQDIQRAMELLSACQGPARNIDEAAKHRYQ :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: NP_004 SGGTKSDSASDSQEIKIQQPSKNPSVPMQKLQDIQRAMELLSACQGPARNIDEAAKHRYQ 70 80 90 100 110 120 130 140 150 160 170 180 pF1KE4 FWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTLLNE :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: NP_004 FWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTLLNE 130 140 150 160 170 180 190 200 210 220 230 240 pF1KE4 NYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRIYDS :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: NP_004 NYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRIYDS 190 200 210 220 230 240 250 260 270 280 290 300 pF1KE4 VKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCRYWH :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: NP_004 VKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCRYWH 250 260 270 280 290 300 310 320 330 340 350 360 pF1KE4 RSLNPKKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINTYLK :::::.:::::::::::::::::::::::::::::::::::::::::::::::::::::: NP_004 RSLNPRKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINTYLK 310 320 330 340 350 360 370 380 390 400 410 420 pF1KE4 QFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKSLKA :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: NP_004 QFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKSLKA 370 380 390 400 410 420 430 440 450 460 470 480 pF1KE4 AYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYL :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: NP_004 AYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYL 430 440 450 460 470 480 490 pF1KE4 YNWRCPGTDSEKVGLVLQ :::::::::::::::::: NP_004 YNWRCPGTDSEKVGLVLQ 490 >>XP_005252699 (OMIM: 603801) PREDICTED: glycylpeptide N (495 aa) initn: 3308 init1: 3308 opt: 3308 Z-score: 3072.7 bits: 578.0 E(85289): 2.1e-164 Smith-Waterman score: 3308; 99.8% identity (100.0% similar) in 492 aa overlap (1-492:1-492) 10 20 30 40 50 60 pF1KE4 MAEDSESAASQQSLELDDQDTCGIDGDNEEETEHAKGSPGGYLGAKKKKKKQKRKKEKPN :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_005 MAEDSESAASQQSLELDDQDTCGIDGDNEEETEHAKGSPGGYLGAKKKKKKQKRKKEKPN 10 20 30 40 50 60 70 80 90 100 110 120 pF1KE4 SGGTKSDSASDSQEIKIQQPSKNPSVPMQKLQDIQRAMELLSACQGPARNIDEAAKHRYQ :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_005 SGGTKSDSASDSQEIKIQQPSKNPSVPMQKLQDIQRAMELLSACQGPARNIDEAAKHRYQ 70 80 90 100 110 120 130 140 150 160 170 180 pF1KE4 FWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTLLNE :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_005 FWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTLLNE 130 140 150 160 170 180 190 200 210 220 230 240 pF1KE4 NYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRIYDS :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_005 NYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRIYDS 190 200 210 220 230 240 250 260 270 280 290 300 pF1KE4 VKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCRYWH :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_005 VKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCRYWH 250 260 270 280 290 300 310 320 330 340 350 360 pF1KE4 RSLNPKKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINTYLK :::::.:::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_005 RSLNPRKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINTYLK 310 320 330 340 350 360 370 380 390 400 410 420 pF1KE4 QFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKSLKA :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_005 QFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKSLKA 370 380 390 400 410 420 430 440 450 460 470 480 pF1KE4 AYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYL :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_005 AYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYL 430 440 450 460 470 480 490 pF1KE4 YNWRCPGTDSEKVGLVLQ :::::::::::: XP_005 YNWRCPGTDSEKKVC 490 >>XP_016872436 (OMIM: 603801) PREDICTED: glycylpeptide N (502 aa) initn: 3308 init1: 3308 opt: 3308 Z-score: 3072.6 bits: 578.0 E(85289): 2.1e-164 Smith-Waterman score: 3308; 99.8% identity (100.0% similar) in 492 aa overlap (1-492:1-492) 10 20 30 40 50 60 pF1KE4 MAEDSESAASQQSLELDDQDTCGIDGDNEEETEHAKGSPGGYLGAKKKKKKQKRKKEKPN :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 MAEDSESAASQQSLELDDQDTCGIDGDNEEETEHAKGSPGGYLGAKKKKKKQKRKKEKPN 10 20 30 40 50 60 70 80 90 100 110 120 pF1KE4 SGGTKSDSASDSQEIKIQQPSKNPSVPMQKLQDIQRAMELLSACQGPARNIDEAAKHRYQ :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 SGGTKSDSASDSQEIKIQQPSKNPSVPMQKLQDIQRAMELLSACQGPARNIDEAAKHRYQ 70 80 90 100 110 120 130 140 150 160 170 180 pF1KE4 FWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTLLNE :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 FWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTLLNE 130 140 150 160 170 180 190 200 210 220 230 240 pF1KE4 NYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRIYDS :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 NYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRIYDS 190 200 210 220 230 240 250 260 270 280 290 300 pF1KE4 VKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCRYWH :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 VKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCRYWH 250 260 270 280 290 300 310 320 330 340 350 360 pF1KE4 RSLNPKKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINTYLK :::::.:::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 RSLNPRKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINTYLK 310 320 330 340 350 360 370 380 390 400 410 420 pF1KE4 QFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKSLKA :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 QFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKSLKA 370 380 390 400 410 420 430 440 450 460 470 480 pF1KE4 AYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYL :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 AYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYL 430 440 450 460 470 480 490 pF1KE4 YNWRCPGTDSEKVGLVLQ :::::::::::: XP_016 YNWRCPGTDSEKALYQPLKKSI 490 500 >>NP_001295224 (OMIM: 603801) glycylpeptide N-tetradecan (485 aa) initn: 2809 init1: 2809 opt: 2814 Z-score: 2615.4 bits: 493.4 E(85289): 6.1e-139 Smith-Waterman score: 2820; 90.6% identity (95.1% similar) in 467 aa overlap (46-498:21-485) 20 30 40 50 60 pF1KE4 LDDQDTCGIDGDNEEETEHAKGSPGGYLGAKKKKKKQKRKKEKPNS-------------- :......::... :.. NP_001 MRRRRSTPKEVLEGIWEPKRKRRNRREKRRNQIPEAPSQTRHLIPRRLKF 10 20 30 40 50 70 80 90 100 110 120 pF1KE4 GGTKSDSASDSQEIKIQQPSKNPSVPMQKLQDIQRAMELLSACQGPARNIDEAAKHRYQF .. .. . : :. .. .:: ::::::::::::::::::::::::::::::::::::::: NP_001 SSLRNTTPSGSR-FQREQP-WNPSVPMQKLQDIQRAMELLSACQGPARNIDEAAKHRYQF 60 70 80 90 100 130 140 150 160 170 180 pF1KE4 WDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTLLNEN :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: NP_001 WDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTLLNEN 110 120 130 140 150 160 190 200 210 220 230 240 pF1KE4 YVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRIYDSV :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: NP_001 YVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRIYDSV 170 180 190 200 210 220 250 260 270 280 290 300 pF1KE4 KKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCRYWHR :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: NP_001 KKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCRYWHR 230 240 250 260 270 280 310 320 330 340 350 360 pF1KE4 SLNPKKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINTYLKQ ::::.::::::::::::::::::::::::::::::::::::::::::::::::::::::: NP_001 SLNPRKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINTYLKQ 290 300 310 320 330 340 370 380 390 400 410 420 pF1KE4 FHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKSLKAA :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: NP_001 FHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKSLKAA 350 360 370 380 390 400 430 440 450 460 470 480 pF1KE4 YSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYLY :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: NP_001 YSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYLY 410 420 430 440 450 460 490 pF1KE4 NWRCPGTDSEKVGLVLQ ::::::::::::::::: NP_001 NWRCPGTDSEKVGLVLQ 470 480 >>XP_016872438 (OMIM: 603801) PREDICTED: glycylpeptide N (482 aa) initn: 2774 init1: 2774 opt: 2779 Z-score: 2583.0 bits: 487.4 E(85289): 3.9e-137 Smith-Waterman score: 2785; 90.2% identity (95.4% similar) in 460 aa overlap (46-492:21-479) 20 30 40 50 60 pF1KE4 LDDQDTCGIDGDNEEETEHAKGSPGGYLGAKKKKKKQKRKKEKPNSGG------------ :......::... :.. . XP_016 MRRRRSTPKEVLEGIWEPKRKRRNRREKRRNQIPEAPSQTRHLIPRRLKF 10 20 30 40 50 70 80 90 100 110 120 pF1KE4 -TKSDSASDSQEIKIQQPSKNPSVPMQKLQDIQRAMELLSACQGPARNIDEAAKHRYQFW . ... ...... .:: :::::::::::::::::::::::::::::::::::::::: XP_016 SSLRNTTPSGSRFQREQP-WNPSVPMQKLQDIQRAMELLSACQGPARNIDEAAKHRYQFW 60 70 80 90 100 130 140 150 160 170 180 pF1KE4 DTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTLLNENY :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 DTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTLLNENY 110 120 130 140 150 160 190 200 210 220 230 240 pF1KE4 VEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRIYDSVK :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 VEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRIYDSVK 170 180 190 200 210 220 250 260 270 280 290 300 pF1KE4 KMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCRYWHRS :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 KMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCRYWHRS 230 240 250 260 270 280 310 320 330 340 350 360 pF1KE4 LNPKKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINTYLKQF :::.:::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 LNPRKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINTYLKQF 290 300 310 320 330 340 370 380 390 400 410 420 pF1KE4 HLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKSLKAAY :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 HLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKSLKAAY 350 360 370 380 390 400 430 440 450 460 470 480 pF1KE4 SFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYLYN :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 SFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYLYN 410 420 430 440 450 460 490 pF1KE4 WRCPGTDSEKVGLVLQ :::::::::: XP_016 WRCPGTDSEKKVC 470 480 >>XP_016872437 (OMIM: 603801) PREDICTED: glycylpeptide N (489 aa) initn: 2774 init1: 2774 opt: 2779 Z-score: 2582.9 bits: 487.4 E(85289): 3.9e-137 Smith-Waterman score: 2785; 90.2% identity (95.4% similar) in 460 aa overlap (46-492:21-479) 20 30 40 50 60 pF1KE4 LDDQDTCGIDGDNEEETEHAKGSPGGYLGAKKKKKKQKRKKEKPNSGG------------ :......::... :.. . XP_016 MRRRRSTPKEVLEGIWEPKRKRRNRREKRRNQIPEAPSQTRHLIPRRLKF 10 20 30 40 50 70 80 90 100 110 120 pF1KE4 -TKSDSASDSQEIKIQQPSKNPSVPMQKLQDIQRAMELLSACQGPARNIDEAAKHRYQFW . ... ...... .:: :::::::::::::::::::::::::::::::::::::::: XP_016 SSLRNTTPSGSRFQREQP-WNPSVPMQKLQDIQRAMELLSACQGPARNIDEAAKHRYQFW 60 70 80 90 100 130 140 150 160 170 180 pF1KE4 DTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTLLNENY :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 DTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTLLNENY 110 120 130 140 150 160 190 200 210 220 230 240 pF1KE4 VEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRIYDSVK :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 VEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRIYDSVK 170 180 190 200 210 220 250 260 270 280 290 300 pF1KE4 KMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCRYWHRS :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 KMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCRYWHRS 230 240 250 260 270 280 310 320 330 340 350 360 pF1KE4 LNPKKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINTYLKQF :::.:::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 LNPRKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINTYLKQF 290 300 310 320 330 340 370 380 390 400 410 420 pF1KE4 HLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKSLKAAY :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 HLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKSLKAAY 350 360 370 380 390 400 430 440 450 460 470 480 pF1KE4 SFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYLYN :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 SFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYLYN 410 420 430 440 450 460 490 pF1KE4 WRCPGTDSEKVGLVLQ :::::::::: XP_016 WRCPGTDSEKALYQPLKKSI 470 480 >>XP_016872442 (OMIM: 603801) PREDICTED: glycylpeptide N (411 aa) initn: 2772 init1: 2772 opt: 2772 Z-score: 2577.6 bits: 486.2 E(85289): 7.8e-137 Smith-Waterman score: 2772; 99.8% identity (100.0% similar) in 411 aa overlap (88-498:1-411) 60 70 80 90 100 110 pF1KE4 KPNSGGTKSDSASDSQEIKIQQPSKNPSVPMQKLQDIQRAMELLSACQGPARNIDEAAKH :::::::::::::::::::::::::::::: XP_016 MQKLQDIQRAMELLSACQGPARNIDEAAKH 10 20 30 120 130 140 150 160 170 pF1KE4 RYQFWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTL :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 RYQFWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTL 40 50 60 70 80 90 180 190 200 210 220 230 pF1KE4 LNENYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRI :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 LNENYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRI 100 110 120 130 140 150 240 250 260 270 280 290 pF1KE4 YDSVKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCR :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 YDSVKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCR 160 170 180 190 200 210 300 310 320 330 340 350 pF1KE4 YWHRSLNPKKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINT ::::::::.::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 YWHRSLNPRKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINT 220 230 240 250 260 270 360 370 380 390 400 410 pF1KE4 YLKQFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKS :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 YLKQFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKS 280 290 300 310 320 330 420 430 440 450 460 470 pF1KE4 LKAAYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQ :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 LKAAYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQ 340 350 360 370 380 390 480 490 pF1KE4 YYLYNWRCPGTDSEKVGLVLQ ::::::::::::::::::::: XP_016 YYLYNWRCPGTDSEKVGLVLQ 400 410 >>XP_016872441 (OMIM: 603801) PREDICTED: glycylpeptide N (415 aa) initn: 2737 init1: 2737 opt: 2737 Z-score: 2545.2 bits: 480.2 E(85289): 5e-135 Smith-Waterman score: 2737; 99.8% identity (100.0% similar) in 405 aa overlap (88-492:1-405) 60 70 80 90 100 110 pF1KE4 KPNSGGTKSDSASDSQEIKIQQPSKNPSVPMQKLQDIQRAMELLSACQGPARNIDEAAKH :::::::::::::::::::::::::::::: XP_016 MQKLQDIQRAMELLSACQGPARNIDEAAKH 10 20 30 120 130 140 150 160 170 pF1KE4 RYQFWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTL :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 RYQFWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTL 40 50 60 70 80 90 180 190 200 210 220 230 pF1KE4 LNENYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRI :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 LNENYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRI 100 110 120 130 140 150 240 250 260 270 280 290 pF1KE4 YDSVKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCR :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 YDSVKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCR 160 170 180 190 200 210 300 310 320 330 340 350 pF1KE4 YWHRSLNPKKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINT ::::::::.::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 YWHRSLNPRKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINT 220 230 240 250 260 270 360 370 380 390 400 410 pF1KE4 YLKQFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKS :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 YLKQFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKS 280 290 300 310 320 330 420 430 440 450 460 470 pF1KE4 LKAAYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQ :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: XP_016 LKAAYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQ 340 350 360 370 380 390 480 490 pF1KE4 YYLYNWRCPGTDSEKVGLVLQ ::::::::::::::: XP_016 YYLYNWRCPGTDSEKALYQPLKKSI 400 410 >>NP_066565 (OMIM: 160993) glycylpeptide N-tetradecanoyl (496 aa) initn: 2569 init1: 2383 opt: 2450 Z-score: 2278.2 bits: 431.0 E(85289): 3.7e-120 Smith-Waterman score: 2515; 73.0% identity (88.6% similar) in 508 aa overlap (1-498:1-496) 10 20 30 40 50 pF1KE4 MAEDSESAASQQSLEL--------DDQDTCGIDGDNEEETEHAKG--SPGGYLGAKKKKK ::..::.:.. . : . .. :. : .:::.. . .: ::.. ::::::: NP_066 MADESETAVKPPAPPLPQMMEGNGNGHEHCS-DCENEEDNSYNRGGLSPANDTGAKKKKK 10 20 30 40 50 60 70 80 90 100 110 pF1KE4 KQKRKKEKPNSGGTKSDSASDSQEIKIQQPSKNPSVPMQKLQDIQRAMELLSACQGPARN :::.:::: :...:::.: :: : :.: ...:.::.:.::.:. ::::.. NP_066 KQKKKKEK----GSETDSAQD-------QPVKMNSLPAERIQEIQKAIELFSVGQGPAKT 60 70 80 90 100 120 130 140 150 160 170 pF1KE4 IDEAAKHRYQFWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEV ..::.:. :::::::::::: ::...:: .::::::.:::::.::::: ::.:::.: : NP_066 MEEASKRSYQFWDTQPVPKLGEVVNTHGPVEPDKDNIRQEPYTLPQGFTWDALDLGDRGV 110 120 130 140 150 160 180 190 200 210 220 230 pF1KE4 LKELYTLLNENYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISA ::::::::::::::::::::::::::::::::::::::: :::::::: :..:::::::: NP_066 LKELYTLLNENYVEDDDNMFRFDYSPEFLLWALRPPGWLPQWHCGVRVVSSRKLVGFISA 170 180 190 200 210 220 240 250 260 270 280 290 pF1KE4 IPANIRIYDSVKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLP :::::.:::. ::::::::::::::::::::::::::::::::.:::::::::::::::: NP_066 IPANIHIYDTEKKMVEINFLCVHKKLRSKRVAPVLIREITRRVHLEGIFQAVYTAGVVLP 230 240 250 260 270 280 300 310 320 330 340 350 pF1KE4 KPIATCRYWHRSLNPKKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKS ::..:::::::::::.::.::::::::::::.::::::::::.. ::.:::::: ::: NP_066 KPVGTCRYWHRSLNPRKLIEVKFSHLSRNMTMQRTMKLYRLPETPKTAGLRPMETKDIPV 290 300 310 320 330 340 360 370 380 390 400 410 pF1KE4 VRELINTYLKQFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVM :..:.. :::::::.:::..::: ::: :.:.::::::::. ::..::::::::::::.: NP_066 VHQLLTRYLKQFHLTPVMSQEEVEHWFYPQENIIDTFVVENANGEVTDFLSFYTLPSTIM 350 360 370 380 390 400 420 430 440 450 460 470 pF1KE4 HHPAHKSLKAAYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFG .::.::::::::::::.::.:::::::::::.::: :::::::::::::::::::::::: NP_066 NHPTHKSLKAAYSFYNVHTQTPLLDLMSDALVLAKMKGFDVFNALDLMENKTFLEKLKFG 410 420 430 440 450 460 480 490 pF1KE4 IGDGNLQYYLYNWRCPGTDSEKVGLVLQ :::::::::::::.::. .:::::::: NP_066 IGDGNLQYYLYNWKCPSMGAEKVGLVLQ 470 480 490 >>XP_011523160 (OMIM: 160993) PREDICTED: glycylpeptide N (515 aa) initn: 2272 init1: 2058 opt: 2125 Z-score: 1977.1 bits: 375.4 E(85289): 2.2e-103 Smith-Waterman score: 2190; 71.2% identity (87.9% similar) in 455 aa overlap (1-445:1-443) 10 20 30 40 50 pF1KE4 MAEDSESAASQQSLEL--------DDQDTCGIDGDNEEETEHAKG--SPGGYLGAKKKKK ::..::.:.. . : . .. :. : .:::.. . .: ::.. ::::::: XP_011 MADESETAVKPPAPPLPQMMEGNGNGHEHCS-DCENEEDNSYNRGGLSPANDTGAKKKKK 10 20 30 40 50 60 70 80 90 100 110 pF1KE4 KQKRKKEKPNSGGTKSDSASDSQEIKIQQPSKNPSVPMQKLQDIQRAMELLSACQGPARN :::.:::: :...:::.: :: : :.: ...:.::.:.::.:. ::::.. XP_011 KQKKKKEK----GSETDSAQD-------QPVKMNSLPAERIQEIQKAIELFSVGQGPAKT 60 70 80 90 100 120 130 140 150 160 170 pF1KE4 IDEAAKHRYQFWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEV ..::.:. :::::::::::: ::...:: .::::::.:::::.::::: ::.:::.: : XP_011 MEEASKRSYQFWDTQPVPKLGEVVNTHGPVEPDKDNIRQEPYTLPQGFTWDALDLGDRGV 110 120 130 140 150 160 180 190 200 210 220 230 pF1KE4 LKELYTLLNENYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISA ::::::::::::::::::::::::::::::::::::::: :::::::: :..:::::::: XP_011 LKELYTLLNENYVEDDDNMFRFDYSPEFLLWALRPPGWLPQWHCGVRVVSSRKLVGFISA 170 180 190 200 210 220 240 250 260 270 280 290 pF1KE4 IPANIRIYDSVKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLP :::::.:::. ::::::::::::::::::::::::::::::::.:::::::::::::::: XP_011 IPANIHIYDTEKKMVEINFLCVHKKLRSKRVAPVLIREITRRVHLEGIFQAVYTAGVVLP 230 240 250 260 270 280 300 310 320 330 340 350 pF1KE4 KPIATCRYWHRSLNPKKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKS ::..:::::::::::.::.::::::::::::.::::::::::.. ::.:::::: ::: XP_011 KPVGTCRYWHRSLNPRKLIEVKFSHLSRNMTMQRTMKLYRLPETPKTAGLRPMETKDIPV 290 300 310 320 330 340 360 370 380 390 400 410 pF1KE4 VRELINTYLKQFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVM :..:.. :::::::.:::..::: ::: :.:.::::::::. ::..::::::::::::.: XP_011 VHQLLTRYLKQFHLTPVMSQEEVEHWFYPQENIIDTFVVENANGEVTDFLSFYTLPSTIM 350 360 370 380 390 400 420 430 440 450 460 470 pF1KE4 HHPAHKSLKAAYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFG .::.::::::::::::.::.:::::::::::.::: XP_011 NHPTHKSLKAAYSFYNVHTQTPLLDLMSDALVLAKMVRSRRGGLWRCAGKRQWSHGEHSS 410 420 430 440 450 460 480 490 pF1KE4 IGDGNLQYYLYNWRCPGTDSEKVGLVLQ XP_011 RDAASHGLEALSPPHLFCLGRVPAVFRQKLKTWREQGASEVKALNSS 470 480 490 500 510 498 residues in 1 query sequences 60827320 residues in 85289 library sequences Tcomplib [36.3.4 Apr, 2011] (8 proc) start: Sat Nov 5 22:35:47 2016 done: Sat Nov 5 22:35:48 2016 Total Scan time: 6.400 Total Display time: 0.050 Function used was FASTA [36.3.4 Apr, 2011]